Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06323057 · ClinicalTrials.gov registry record · NA
Modulating Reward Learning Using Transcranial Magnetic Stimulation
A NA study of Behavior, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- NA
- Development phase
- 28
- Enrollment target
- 1
- Study location
NCT06323057: Recruiting NA study of Behavior, sponsored by Rutgers, The State University of New Jersey.
NCT06323057 is a NA study of Behavior that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 28 participants, below the 4,864-participant average among 23 other Behavior trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06323057, a NA study of Behavior, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
- 1
- Study location
Study Summary
Our specific aim is to examine the effects of TMS on reward processing during goal-directed behavior. In these experiments the investigators will utilize a scalp-recorded brain oscillation called frontal midline theta that is believed to index the sensitivity of the cingulate cortex to reward feedback. Here the investigators will asked whether this electrophysiological signal can be modulated up or down using TMS while participants engage in decision making tasks, and if so, whether it would affect the encoding of rewards and subsequent choices during task performance.
Primary Outcome
Frontal-midline theta (FMT: 4-8 hz) is a scalp recorded brain oscillation sensitive to the processing of reward stimulus presented during decision making tasks. FMT will be measured during the presentation of the reward stimulus (Reward, No-reward) during task performance. A time-frequency analysis will be used to measure FMT power for each electrode by averaging the single-trial EEG according to feedback type (reward and no-reward). The size of the FMT will be determined by identifying the maxi
Conditions Studied
Interventions
- DEVICE Single pulse TMS to the frontal cortex
Study Locations (1)
New Jersey
- Rutgers University - Newark - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2024-02-14 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT06323057 shows while recruiting
NCT06323057 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 4,864-participant average among 23 other Behavior trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Behavior appearing as the primary indexed condition, and to 1 intervention - of which Single pulse TMS to the frontal cortex is the first listed.
NCT06323057 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06323057 about?
NCT06323057 is a clinical study titled "Modulating Reward Learning Using Transcranial Magnetic Stimulation". Our specific aim is to examine the effects of TMS on reward processing during goal-directed behavior. In these experiments the investigators will utilize a scalp-recorded brain oscillation called frontal midline theta that is believed to index the sensitivity of the cingulate cortex to reward feedba...
What is the current status of trial NCT06323057?
This trial is currently recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2024-02-14. Estimated completion is 2026-04-30.
What conditions does trial NCT06323057 study?
This clinical trial studies the following conditions: Behavior.
What interventions are being tested in trial NCT06323057?
The interventions under investigation include: Single pulse TMS to the frontal cortex (DEVICE).
Who is sponsoring clinical trial NCT06323057?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06323057 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06323057's enrollment target sits among peer trials
28 22nd of 23 higher than 2 of 23 other Behavior trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Behavior trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Therapy Dogs on Child Anxiety and Behavior During Local Anesthesia for Dental Procedures
RECRUITING · NA
-
Socialization To Enrich Participation & Support Sexuality for Young People With I/DD
RECRUITING · NA
-
Pilot Trial of the RUBI Program for Autistic Adults
RECRUITING · NA
-
Studies of Human Inference Using On-line Testing
RECRUITING · NA
-
The VESPA Pilot Study
RECRUITING · NA
-
Mobile Health Technology-Enabled AFib Management
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI